Wall Street Has Been Betting on Your Death Since the AIDS Crisis

The Cancer Survivor Who Accidentally Found His Own Price Tag

Frank Sierawski was 35 when he got diagnosed with a rare Stage IV lung cancer. He had a wife, three kids, and a five-year survival rate of twenty percent. He set what he called an ambitious goal at the time: live seven years. He is 47 now, which means he cleared it.

As NPR's Planet Money reports, Sierawski kept paying into two life insurance policies through his diagnosis, through remission, through all of it. Then, a little over a year ago, he was scrolling through a Facebook group for cancer survivors and came across a post that reframed everything he thought he understood about what a life insurance policy even is.

The post described something called a life settlement. The deal is straightforward and quietly unsettling: you sell your policy to an investor for a fraction of its face value, maybe twenty to thirty cents on the dollar. The investor takes over premium payments. When you die, they collect the full payout instead of your family. You get cash now. They get a return on a timeline determined by your biology.

"It's an asset I didn't know I had," Sierawski told Planet Money. "Which was like, whoa, mind-blowing." He is a finance guy, so he did the next logical thing: he filled out some forms online to see what his cancer history might be worth on the open market. His phone, he says, immediately started ringing off the hook.

How This Is Legal: A 1911 Supreme Court Ruling and Zero Moral Imagination

Here is the part where you ask how any of this is legal, and the answer is: the Supreme Court, a century ago, said it was fine, probably without fully thinking through what "Wall Street death portfolio" would eventually mean.

Back in the early 1900s, according to Planet Money's reporting, a man sold his life insurance policy to his doctor for a hundred dollars to cover the cost of an operation. When he died, his insurance company went to court to figure out who it owed: the doctor or the dead man's estate. The case went to the Supreme Court.

The court was navigating a genuine tension. On one side sat the principle of "insurable interest," the long-standing rule that you can only take out a policy on someone whose death would actually hurt you financially or emotionally. The logic is simple: if you could insure a stranger's life, you would have a significant financial incentive for that stranger to die quickly. The court called that, with some understatement, "a pure wager."

But the court drew a line. If you took out the policy on yourself or on someone whose death would legitimately harm you, it ruled in 1911, the policy was yours. Your property. To do with as you pleased, including sell it to anyone who wanted to buy it. That ruling planted the legal seed. It took eighty years and a catastrophe for it to actually grow into something.

Greg Was Dying and the Bills Were Piling Up

The catastrophe was AIDS. The man who inadvertently built this market was Scott Page, who had moved across the country to be with his partner Greg, a carpenter who was dying of the disease.

As Planet Money reports, Page and Greg developed a grim household ritual: sorting through the mail together to figure out which bills they absolutely had to pay and which ones they could safely ignore for another month. One day, shuffling through that stack, Page found a letter from Greg's life insurance company.

Greg could not work anymore. They were out of money and out of options. What that letter represented, and what Page was beginning to understand, was that the policy Greg had been paying into was not just a promise that paid out when he died. It was something that existed right now, while he was still alive, and might have value to someone.

That realization, born entirely from desperation, from two men trying to survive a plague that the federal government was largely pretending not to notice, is the direct origin of what is now a multibillion-dollar institutional investment class. Binders full of policies on people like Sierawski, sitting in portfolios, being managed like any other asset. Wall Street waited for AIDS patients to die in the 1980s because there was money in it. It has been refining the model ever since.

From Handshake Deals to Wall Street Asset Class

What started as informal, desperate arrangements between dying men and the people willing to buy their policies eventually caught the attention of institutional money. The math is not complicated. You buy a policy at a discount. You keep paying the premium. The person dies. You collect. The faster they die, the better your internal rate of return. That is the investment thesis, stated plainly.

Planet Money's reporting traces how those loose handshake deals from the AIDS crisis formalized over decades into a structured, regulated, and genuinely enormous market. Policyholders become line items. Their remaining life expectancy is modeled, priced, and traded. The industry prefers language like "life expectancy underwriting" because "we are calculating when we expect you to die so we can price your policy" does not play as well in a pitch deck.

For sellers, there is a real case to be made. Sierawski was looking at policies he no longer needed the same way he once did, and selling them could mean actual cash in hand today rather than a payout his family might collect years from now. The market does provide liquidity for people in genuine need. That part is true and worth acknowledging.

The Part That Should Make You a Little Uncomfortable

The seller-side argument for life settlements is legitimate. The thing that sits wrong is the buy side, and it is worth sitting with that discomfort for a moment.

The investors who purchase these policies make the most money when the person who sold the policy dies as quickly as possible after the sale. That is not a conspiracy theory or an uncharitable reading of the market. It is just arithmetic. Planet Money put it simply: companies that buy life settlements want their returns as fast as possible, and they make the most when someone dies the day after the sale closes.

Sierawski understood this instantly because he works in finance. His cancer history, the thing that devastated his life at 35, made him a more attractive product. A more valuable line item. That is the part the industry does not love to talk about at conferences.